Clinical trial shows rheumatoid arthritis drug could prevent disease
- Details
- Category: Research
Results from a Phase 2b clinical trial, published in The Lancet by researchers led by King's College London, provides hope for arthritis sufferers after it was shown that the biologic drug abatacept reduces progression to this agonising chronic inflammatory disease.
Cleveland Clinic research reveals unique tumor-related bacteria tied to young-onset colorectal cancer
- Details
- Category: Research
The research reveals differences in tumor-related bacteria associated with young-onset colorectal cancer.
Vaccine shows promise against CMV, a virus that causes birth defects
- Details
- Category: Research
Using cancer's strength to fight against it
- Details
- Category: Research
By studying mutations in malignant T cells that cause lymphoma, they zeroed in on one that imparted exceptional potency to engineered T cells. Inserting a gene encoding this unique mutation into normal human T cells made them more than 100 times more potent at killing cancer cells without any signs of becoming toxic.
Chapman scientists code ChatGPT to design new medicine
- Details
- Category: Research
Today, scientists use advanced technology to design new synthetic drug compounds with the right properties and characteristics, also known as "de novo drug design." However, current methods can be labor-, time-, and cost-intensive.
Vividion Therapeutics starts Phase I clinical trial in advanced solid and hematologic tumors with oral STAT3 inhibitor
- Details
- Category: Bayer
MSU researchers find early, promising glioblastoma treatment
- Details
- Category: Research
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer.
The American Cancer Society and Pfizer announce a $15 million, three-year initiative to bridge the gap in cancer care disparities
- Details
- Category: Pfizer
Cheating death: How cancer cells escape
- Details
- Category: Research
US prescription drug prices are 2.78 times those in other wealthy nations
- Details
- Category: Development
The gap between prices in the U.S. and other countries is even larger for brand-named drugs, with U.S. prices averaging 4.22 times those in comparison nations.